PedAM
Pediatric Disease Annotations & Medicines
| allergic cutaneous vasculitis | ||||
| Disease ID | 1301 |
|---|---|
| Disease | allergic cutaneous vasculitis |
| Definition | Disorder characterized by a vasculitic syndrome associated with exposure to an antigen such as a drug, infectious agent, or other foreign or endogenous substance. Its pathophysiology includes immune complex deposition and a wide range of skin lesions. Hypersensitivity or allergy is present in some but not all cases. |
| Synonym | allergic cutaneous angiitides allergic cutaneous angiitis allergic cutaneous vasculitides allergic vasculitides, cutaneous allergic vasculitis allergic vasculitis, cutaneous angiitides, allergic cutaneous angiitides, cutaneous leukocytoclastic angiitides, hypersensitivity angiitis, allergic cutaneous angiitis, cutaneous leukocytoclastic angiitis, hypersensitivity angiitis, leukocytoclastic cutaneous allergic vasculitides cutaneous allergic vasculitis cutaneous angiitides, allergic cutaneous angiitis, allergic cutaneous hypersensitivity vasculitis cutaneous leucocytoclastic angiitis cutaneous leukocytoclastic angiitides cutaneous leukocytoclastic angiitis cutaneous leukocytoclastic angiitis (disorder) cutaneous leukocytoclastic vasculitides cutaneous leukocytoclastic vasculitis cutaneous small vessel vasculitis cutaneous vasculitides, allergic cutaneous vasculitis, allergic hypersensit angiitis nos hypersensitivity angiitides hypersensitivity angiitis hypersensitivity angiitis (disorder) hypersensitivity angiitis nos hypersensitivity angiitis nos (disorder) hypersensitivity angiitis, unspecified hypersensitivity vasculitides hypersensitivity vasculitis leucocytoclastic angiitis leucocytoclastic vasculitis leukocytoclastic angiitides, cutaneous leukocytoclastic angiitis leukocytoclastic angiitis, cutaneous leukocytoclastic vasculitides, cutaneous leukocytoclastic vasculitis leukocytoclastic vasculitis, cutaneous maladie trisymptome trisymptome vasculitides, allergic cutaneous vasculitides, cutaneous allergic vasculitides, cutaneous leukocytoclastic vasculitides, hypersensitivity vasculitis allergic vasculitis leukocytoclastic vasculitis nonspecific allergic vasculitis nonspecific allergic hypersensitivity vasculitis vasculitis, allergic vasculitis, allergic cutaneous vasculitis, cutaneous allergic vasculitis, cutaneous leukocytoclastic vasculitis, hypersensitivity vasculitis, leukocytoclastic vasculitis, leukocytoclastic, cutaneous vasculitis, leukocytoclastic, cutaneous [disease/finding] |
| Orphanet | |
| DOID | |
| ICD10 | |
| UMLS | C0151436 |
| MeSH | |
| SNOMED-CT | |
| Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:3) C0151436 | leukocytoclastic vasculitis | 2 C0004623 | bacterial infection | 1 C0042384 | vasculitis | 1 |
| Curated Gene | (Waiting for update.) |
| Inferring Gene | (Waiting for update.) |
| Text Mined Gene | Entrez_id | Symbol | Score | Resource(Total Genes:105) 6376 | CX3CL1 | DISEASES 5603 | MAPK13 | DISEASES 623 | BDKRB1 | DISEASES 4210 | MEFV | DISEASES 8797 | TNFRSF10A | DISEASES 973 | CD79A | DISEASES 56913 | C1GALT1 | DISEASES 4353 | MPO | DISEASES 40 | ASIC2 | DISEASES 6347 | CCL2 | DISEASES 3558 | IL2 | DISEASES 41 | ASIC1 | DISEASES 3458 | IFNG | DISEASES 3565 | IL4 | DISEASES 5657 | PRTN3 | DISEASES 3623 | INHA | DISEASES 718 | C3 | DISEASES 5199 | CFP | DISEASES 3306 | HSPA2 | DISEASES 968 | CD68 | DISEASES 79148 | MMP28 | DISEASES 8431 | NR0B2 | DISEASES 6737 | TRIM21 | DISEASES 1401 | CRP | DISEASES 2799 | GNS | DISEASES 3569 | IL6 | DISEASES 3557 | IL1RN | DISEASES 7097 | TLR2 | DISEASES 10068 | IL18BP | DISEASES 7450 | VWF | DISEASES 3383 | ICAM1 | DISEASES 26277 | TINF2 | DISEASES 6687 | SPG7 | DISEASES 7356 | SCGB1A1 | DISEASES 55079 | FEZF2 | DISEASES 4325 | MMP16 | DISEASES 1636 | ACE | DISEASES 643 | CXCR5 | DISEASES 6352 | CCL5 | DISEASES 3889 | KRT83 | DISEASES 7412 | VCAM1 | DISEASES 213 | ALB | DISEASES 5648 | MASP1 | DISEASES 9311 | ASIC3 | DISEASES 56547 | MMP26 | DISEASES 719 | C3AR1 | DISEASES 6037 | RNASE3 | DISEASES 661 | POLR3D | DISEASES 929 | CD14 | DISEASES 29071 | C1GALT1C1 | DISEASES 375611 | SLC26A5 | DISEASES 3627 | CXCL10 | DISEASES 5066 | PAM | DISEASES 157570 | ESCO2 | DISEASES 2147 | F2 | DISEASES 84868 | HAVCR2 | DISEASES 4327 | MMP19 | DISEASES 1776 | DNASE1L3 | DISEASES 6401 | SELE | DISEASES 3320 | HSP90AA1 | DISEASES 114548 | NLRP3 | DISEASES 123283 | TARSL2 | DISEASES 3572 | IL6ST | DISEASES 29949 | IL19 | DISEASES 545 | ATR | DISEASES 3605 | IL17A | DISEASES 26762 | HAVCR1 | DISEASES 728 | C5AR1 | DISEASES 2204 | FCAR | DISEASES 355 | FAS | DISEASES 5265 | SERPINA1 | DISEASES 2224 | FDPS | DISEASES 23556 | PIGN | DISEASES 5169 | ENPP3 | DISEASES 26191 | PTPN22 | DISEASES 4192 | MDK | DISEASES 3123 | HLA-DRB1 | DISEASES 183 | AGT | DISEASES 80222 | TARS2 | DISEASES 959 | CD40LG | DISEASES 4318 | MMP9 | DISEASES 129685 | TAF8 | DISEASES 4153 | MBL2 | DISEASES 7099 | TLR4 | DISEASES 169981 | SPIN3 | DISEASES 7133 | TNFRSF1B | DISEASES 1471 | CST3 | DISEASES 7056 | THBD | DISEASES 83715 | ESPN | DISEASES 5420 | PODXL | DISEASES 5277 | PIGA | DISEASES 64423 | INF2 | DISEASES 5076 | PAX2 | DISEASES 720 | C4A | DISEASES 7124 | TNF | DISEASES 3106 | HLA-B | DISEASES 7148 | TNXB | DISEASES 3920 | LAMP2 | DISEASES 1589 | CYP21A2 | DISEASES 389549 | FEZF1 | DISEASES 3586 | IL10 | DISEASES 721 | C4B | DISEASES 56 | ACRV1 | DISEASES 567 | B2M | DISEASES 7732 | RNF112 | DISEASES |
| Locus | (Waiting for update.) |
| Disease ID | 1301 |
|---|---|
| Disease | allergic cutaneous vasculitis |
| Integrated Phenotype | (Waiting for update.) |
| Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:1) |
| Disease ID | 1301 |
|---|---|
| Disease | allergic cutaneous vasculitis |
| Manually Symptom | (Waiting for update.) |
| Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
|---|
| (Waiting for update.) |
All Snps(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Annotation(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Snp Trait(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
Mapped by lexical matching(Total Items:0) |
|---|
| (Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
|---|
| (Waiting for update.) |
Chemical(Total Drugs:50) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
| C0151436 | acetaminophen | D000082 | 103-90-2 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 19078133 | ||
| C0151436 | atenolol | D001262 | 29122-68-7 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 17659030 | ||
| C0151436 | azithromycin | D017963 | 83905-01-5 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 14528532 | ||
| C0151436 | bortezomib | D000069286 | - | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 17635511 | ||
| C0151436 | carbamazepine | D002220 | 298-46-4 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 3668581 | ||
| C0151436 | carbimazole | D002231 | 22232-54-8 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 10327480 | ||
| C0151436 | celecoxib | D000068579 | - | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 12219273 | ||
| C0151436 | chloroquine | D002738 | 1954/5/7 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 12735648 | ||
| C0151436 | chlorzoxazone | D002753 | 95-25-0 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 14746633 | ||
| C0151436 | cimetidine | D002927 | 51481-61-9 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 6638053 | ||
| C0151436 | cimetidine | D002927 | 51481-61-9 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | therapeutic | 7443604 | ||
| C0151436 | ciprofloxacin | D002939 | 85721-33-1 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 10893785 | ||
| C0151436 | clozapine | D003024 | 5786-21-0 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 16055784 | ||
| C0151436 | cyclophosphamide | D003520 | 50-18-0 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 2764806 | ||
| C0151436 | cyclophosphamide | D003520 | 50-18-0 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | therapeutic | 17657683 | ||
| C0151436 | diltiazem | D004110 | 42399-41-7 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 3211830 | ||
| C0151436 | doxycycline | D004318 | 564-25-0 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 6268571 | ||
| C0151436 | enalapril | D004656 | 75847-73-3 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 9797501 | ||
| C0151436 | everolimus | D000068338 | - | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 16753882 | ||
| C0151436 | famciclovir | C060590 | 104227-87-4 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 16004023 | ||
| C0151436 | haloperidol | D006220 | 52-86-8 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 10564343 | ||
| C0151436 | indinavir | D019469 | 150378-17-9 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 11069541 | ||
| C0151436 | indomethacin | D007213 | 53-86-1 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 3381715 | ||
| C0151436 | leuprolide | D016729 | 53714-56-0 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 17611838 | ||
| C0151436 | liposomal amphotericin b | C068538 | - | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 18076602 | ||
| C0151436 | mefloquine | D015767 | 53230-10-7 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 10457122 | ||
| C0151436 | metformin | D008687 | 657-24-9 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 16882868 | ||
| C0151436 | methotrexate | D008727 | 1959/5/2 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 11105634 | ||
| C0151436 | metolazone | D008788 | 17560-51-9 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 1946137 | ||
| C0151436 | nicotine | D009538 | - | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 8746358 | ||
| C0151436 | ofloxacin | D015242 | 82419-36-1 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 12852373 | ||
| C0151436 | olanzapine | C076029 | 132539-06-1 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 16089244 | ||
| C0151436 | omeprazole | D009853 | 73590-58-6 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 11807212 | ||
| C0151436 | pantoprazole | C064276 | 102625-70-7 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 16482642 | ||
| C0151436 | peginterferon alfa-2a | C100416 | - | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 18187830 | ||
| C0151436 | phenytoin | D010672 | 57-41-0 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 1147459 | ||
| C0151436 | piperazine | C034930 | 110-85-0 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 9158321 | ||
| C0151436 | propranolol | D011433 | 525-66-6 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 10907976 | ||
| C0151436 | propylthiouracil | D011441 | 51-52-5 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 10088956 | ||
| C0151436 | ribavirin | D012254 | 36791-04-5 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 18187830 | ||
| C0151436 | rifampin | D012293 | 13292-46-1 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 2736984 | ||
| C0151436 | sirolimus | D020123 | 53123-88-9 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 12352895 | ||
| C0151436 | sotalol | D013015 | 3930-20-9 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 17659030 | ||
| C0151436 | thalidomide | D013792 | 50-35-1 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 17709605 | ||
| C0151436 | thalidomide | D013792 | 50-35-1 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | therapeutic | 2985516 | ||
| C0151436 | ticlopidine | D013988 | 55142-85-3 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 11141463 | ||
| C0151436 | valproic acid | D014635 | 99-66-1 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 1671504 | ||
| C0151436 | vancomycin | D014640 | 1404-90-6 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 19558258 | ||
| C0151436 | vigabatrin | D020888 | 60643-86-9 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 8164764 | ||
| C0151436 | zidovudine | D015215 | 30516-87-1 | vasculitis, leukocytoclastic, cutaneous | MESH:D018366 | marker/mechanism | 1558446 | ||
FDA approved drug and dosage information(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |
FDA labeling changes(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |